Valiant Laboratories Profile
Key Indicators
- Authorised Capital ₹ 45.00 Cr
as on 08-11-2024
- Paid Up Capital ₹ 43.45 Cr
as on 08-11-2024
- Company Age 3 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 61.40 Cr
as on 08-11-2024
- Satisfied Charges ₹ 52.00 Cr
as on 08-11-2024
About Valiant Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 45.00 Cr and a paid-up capital of Rs 43.45 Cr.
The company currently has active open charges totaling ₹61.40 Cr. The company has closed loans amounting to ₹52.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Valiant Laboratories Limited India are Paresh Shah as CFO and Prajakta Patil as Company Secretary. Velji Gogri, Mulesh Savla, Shantilal Vora, and Four other members serve as directors at the Company.
- CIN/LLPIN
L24299MH2021PLC365904
- Company No.
365904
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 Aug 2021
- Date of AGM
13 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Valiant Laboratories?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santosh Vora  | Managing Director | 16-Aug-2021 | Current |
| Paresh Shah | CFO | 06-Feb-2022 | Current |
| Prajakta Patil | Company Secretary | 11-Jun-2024 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Velji Gogri | Director | 06-Feb-2022 | Current |
| Mulesh Savla | Additional Director | 11-Jun-2024 | Current |
| Shantilal Vora | Director | 16-Aug-2021 | Current |
| Paresh Shah | Director | 16-Aug-2021 | Current |
| Sandeep Gupta | Director | 23-Feb-2023 | Current |
| Sonal Vira | Director | 16-Feb-2022 | Current |
Financial Performance of Valiant Laboratories.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Valiant Laboratories?
Unlock access to Valiant Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Valiant Organics LimitedActive 19 years 10 monthsMulesh Savla, Santosh Vora and 1 more are mutual person
- Valiant Advanced Sciences Private LimitedActive 2 years 5 months
Santosh Vora, Paresh Shah and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 08 Jun 2024 | ₹4.40 Cr | Open |
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 28 Feb 2024 | ₹5.00 Cr | Open |
Others Creation Date: 23 Sep 2022 | ₹52.00 Cr | Open |
How Many Employees Work at Valiant Laboratories?
Unlock and access historical data on people associated with Valiant Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Valiant Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Valiant Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
